Emulation of a Target Trial From Observational Data to Compare Effectiveness of Casirivimab/Imdevimab and Bamlanivimab/Etesevimab for Early Treatment of Non-Hospitalized Patients With COVID-19

OBJECTIVES: Comparative analysis between different monoclonal antibodies (mAbs) against SARS-CoV-2 are lacking. We present an emulation trial from observational data to compare effectiveness of Bamlanivimab/Etesevimab (BAM/ETE) and Casirivimab/Imdevimab (CAS/IMD) in outpatients with early mild-to-mo...

Descripción completa

Detalles Bibliográficos
Autores principales: Mazzotta, Valentina, Cozzi-Lepri, Alessandro, Colavita, Francesca, Lanini, Simone, Rosati, Silvia, Lalle, Eleonora, Mastrorosa, Ilaria, Cimaglia, Claudia, Vergori, Alessandra, Bevilacqua, Nazario, Lapa, Daniele, Mariano, Andrea, Bettini, Aurora, Agrati, Chiara, Piselli, Pierluca, Girardi, Enrico, Castilletti, Concetta, Garbuglia, Anna Rosa, Vaia, Francesco, Nicastri, Emanuele, Antinori, Andrea
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9066636/
https://www.ncbi.nlm.nih.gov/pubmed/35514955
http://dx.doi.org/10.3389/fimmu.2022.868020

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9066636/
https://www.ncbi.nlm.nih.gov/pubmed/35514955
http://dx.doi.org/10.3389/fimmu.2022.868020

Ejemplares similares